MGA Releases Economic Impact Report for Multinational Pharmaceutical Company
In a newly released report, MGA highlights the broad economic impact of Otsuka in the United States. A leader in mental health and nephrology treatments, Otsuka offers both pharmaceuticals and digital healthcare solutions.
Utilizing an input-output model of the US economy built by IMPLAN, MGA finds that Otsuka supported 10,520 US jobs, generated $1.2 billion in labor income (a measure of wages), and contributed $2.7 billion in economic output in the United States in 2022. (See below for a breakdown of the results.)
The MGA report also highlights the broader health and social impact of Otsuka in the United States, including R&D, corporate social responsibility, and patient support and advocacy.
